LakeShore Biopharma 10-Q 22 Nov 21 2021 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2021	Nov. 19, 2021
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Entity Registrant Name	SUMMIT HEALTHCARE ACQUISITION CORP.
Entity Central Index Key	0001839185
Document Period End Date	Sep. 30, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity Incorporation, State or Country Code	E9
Entity File Number	001-40466
Entity Tax Identification Number	98-1574360
Entity Address, Address Line One	Unit 1101
Entity Address, Address Line Two	11th Floor
Entity Address, Address Line Three	1 Lyndhurst Tower, 1 Lyndhurst Terrace
Entity Address, City or Town	Central
Entity Address, Country	HK
Entity Address, Postal Zip Code	00000
City Area Code	852
Local Phone Number	9162-5199
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Common Class A
Document Information [Line Items]
Title of 12(b) Security	Class A ordinary shares, par value $0.0001per share
Trading Symbol	SMIH
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		20,000,000
Common Class B
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		5,750,000
Warrant
Document Information [Line Items]
Title of 12(b) Security	Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Trading Symbol	SMIHW
Security Exchange Name	NASDAQ
Capital Units
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
Trading Symbol	SMIHU
Security Exchange Name	NASDAQ

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)		Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash		$ 1,075,137
Prepaid expenses		221,704
Total current assets		1,296,841
Deferred offering costs			$ 91,374
Investments held in Trust Account		200,003,049
Total Assets		201,299,890	91,374
Current liabilities:
Accrued offering costs and expenses		72,619	65,000
Due to related party		37,667
Note payable – related party		0	5,010
Total current liabilities		110,286	70,010
Warrant liability		13,800,974
Deferred underwriting commissions		7,000,000
Total Liabilities		23,718,281	70,010
Commitments and Contingencies (Note 8)
Class A ordinary shares, $0.0001 par value; 20,000,000 shares and -0- shares subject to possible redemption at $10.00 per share at September 30, 2021 and December 31, 2020, respectively		200,000,000
Shareholders' (Deficit) Equity:
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding
Additional paid-in capital			24,350
Accumulated deficit		(22,418,966)	(3,636)
Total shareholders' (Deficit) Equity		(22,418,391)	21,364
Total Liabilities, Class A ordinary shares subject to possible redemption and Shareholders' (Deficit) Equity		201,299,890	91,374
Common Class A
Current liabilities:
Class A ordinary shares, $0.0001 par value; 20,000,000 shares and -0- shares subject to possible redemption at $10.00 per share at September 30, 2021 and December 31, 2020, respectively		200,000,000
Shareholders' (Deficit) Equity:
Common Stock		0
Total shareholders' (Deficit) Equity		0	0
Common Class B
Shareholders' (Deficit) Equity:
Common Stock	[1]	575	650
Total shareholders' (Deficit) Equity		575	$ 650
FPA
Current liabilities:
Warrant liability		$ 2,807,021
[1]	This number includes up to 750,000 Class B ordinary shares subject to forfeiture as of December 31, 2020. On July 23, 2021, the 750,000 Class B ordinary shares were forfeited when the overallotment option expired

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Jul. 23, 2021	Sep. 30, 2021	Dec. 31, 2020
Preferred stock par or stated value per share		$ 0.0001	$ 0.0001
Preferred stock shares authorized		5,000,000	5,000,000
Preferred stock shares issued		0	0
Preferred stock shares outstanding		0	0
Number of Shares Forfeited During the Period		0
Common Class A
Temporary Equity, Par or Stated Value Per Share		$ 0.0001	$ 0.0001
Temporary Equity, Shares Outstanding		20,000,000	0
Temporary Equity, Redemption Price Per Share		$ 10	$ 10
Common stock par or stated value per share		$ 0.0001	$ 0.0001
Common stock shares authorized		500,000,000	500,000,000
Common stock shares issued			0
Common stock shares outstanding			0
Common Class B
Common stock par or stated value per share		$ 0.0001	$ 0.0001
Common stock shares authorized		50,000,000	50,000,000
Common stock shares issued		5,750,000	6,500,000
Common stock shares outstanding		5,750,000	6,500,000
Number of Shares Forfeited During the Period			750,000
Number of Overallotment Shares Forfeited During the Period	750,000

Condensed Statements of Operati

Condensed Statements of Operations - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021
General and administrative expenses	$ 202,904	$ 246,868
Loss from operations	(202,904)	(246,868)
Other income (expense):
Change in fair value of FPA	(561,983)	(2,807,021)
Change in fair value of warrant liability	1,797,111	(88,010)
Transaction costs allocable to warrants	0	(507,417)
Interest earned on investments held in Trust Account	2,573	3,049
Other income (loss)	1,237,701	(3,399,399)
Net income (Loss)	$ 1,034,797	$ (3,646,267)
Class A Common Stock Subject To Possible Redemption
Other income (expense):
Basic and diluted weighted average shares outstanding	20,000,000	8,205,128
Basic and diluted net income (loss) per ordinary shares	$ 0.04	$ (0.26)
Class B Shares Outstanding, NonRedeemable Ordinary Share
Other income (expense):
Basic and diluted weighted average shares outstanding	5,750,000	5,750,000
Basic and diluted net income (loss) per ordinary shares	$ 0.04	$ (0.26)

Condensed Statements of Changes

Condensed Statements of Changes in Shareholders' (Deficit) Equity - USD ($)	Total	Additional Paid-in Capital	Accumulated Deficit	Common Class A	Common Class B
Balances at beginning at Dec. 31, 2020	$ 21,364	$ 24,350	$ (3,636)	$ 0	$ 650
Balances at beginning, Shares at Dec. 31, 2020				0	6,500,000
Excess of private placement proceed over fair value as capital contribution	798,445	798,445
Accretion of Class A ordinary shares to redemption value	(19,591,933)	(822,795)	(18,769,138)
Net loss	(4,681,064)		(4,681,064)
Balances at end at Jun. 30, 2021	(23,453,188)	0	(23,453,838)	$ 0	$ 650
Balances at end, Shares at Jun. 30, 2021				0	6,500,000
Balances at beginning at Dec. 31, 2020	21,364	24,350	(3,636)	$ 0	$ 650
Balances at beginning, Shares at Dec. 31, 2020				0	6,500,000
Accretion of Class A ordinary shares to redemption value				$ (19,591,933)
Net loss	(3,646,267)			(2,143,878)	$ (1,502,389)
Balances at end at Sep. 30, 2021	(22,418,391)	0	(22,418,966)	$ 0	$ 575
Balances at end, Shares at Sep. 30, 2021				0	5,750,000
Balances at beginning at Jun. 30, 2021	(23,453,188)	0	(23,453,838)	$ 0	$ 650
Balances at beginning, Shares at Jun. 30, 2021				0	6,500,000
Forfeiture of founder shares			75		$ (75)
Forfeiture of founder shares, Shares					(750,000)
Net loss	1,034,797		1,034,797	$ 803,726	$ 231,071
Balances at end at Sep. 30, 2021	$ (22,418,391)	$ 0	$ (22,418,966)	$ 0	$ 575
Balances at end, Shares at Sep. 30, 2021				0	5,750,000

Condensed Statement of Cash Flo

Condensed Statement of Cash Flows - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021
Cash Flows from Operating Activities:
Net loss	$ 1,034,797	$ (3,646,267)
Adjustments to reconcile net loss to net cash provided by operating activities:
Interest earned on investments held in Trust Account		(3,049)
Change in fair value of FPA liability	561,983	2,807,021
Change in fair value of warrant liability	(1,797,111)	88,010
Transaction costs allocable to warrants	0	507,417
Changes in operating assets and liabilities:
Prepaid expenses		(221,704)
Accrued offering costs and expenses		7,619
Due to related party		37,667
Net cash used in operating activities		(423,286)
Cash Flows from Investing Activities
Investment of cash in Trust Account		(200,000,000)
Net cash used in investing activities		(200,000,000)
Cash Flows from Financing Activities:
Proceeds received from initial public offering, net of underwriters' discount		196,000,000
Proceeds from private placement		6,000,000
Payment of offering costs		(140,554)
Repayment of note payable from related party		(361,023)
Net cash provided by financing activities		201,498,423
Net change in cash		1,075,137
Cash, beginning of the period		0
Cash, end of the period	$ 1,075,137	1,075,137
Supplemental Non-cash disclosure of cash flow information:
Deferred offering costs paid by Sponsor under promissory note		135,544
Deferred underwriting commissions		$ 7,000,000

Organization, Business Operatio

Organization, Business Operation and Going Concern Consideration	9 Months Ended
	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Business Operation and Going Concern Consideration	Note 1 — Organization, Business Operation and Going Concern Consideration Summit Healthcare Acquisition Corp. (the “Company”) is a blank check company incorporated on December 22, 2020 as a Cayman Islands exempted company. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company has not selected any specific Business Combination target under consideration or contemplation and the Company has not, nor has anyone on its behalf, contacted any prospective target business or had any discussions, formal or otherwise, with respect to such a transaction. The Company’s efforts to identify a prospective target business will not be limited to a particular geographic region or industry, although it intends to focus on healthcare. As of September 30, 2021, the Company had not commenced any operations. All activity for the period from December 22, 2020 (inception) through September 30, 2021 relates to the Company’s formation and the initial public offering (the “IPO”). The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in The Company’s Sponsor is Summit Healthcare Acquisition Sponsor LLC, a Cayman Islands limited liability company (the “Sponsor”). The registration statement for the Company’s IPO was declared effective on June 8, 2021 (the “Effective Date”). On June 11, 2021, the Company consummated the IPO of 20,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”) 10.00 per Unit, generating gross proceeds of $200,000,000, which is discussed in Note 4. Simultaneously with the consummation of the IPO and the issuance and sale of the Units, the Company consummated the private placement of 6,000,000 Private Placement Warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant, to the Sponsor, generating total proceeds of $6,000,000. Transaction costs amounted to $11,587,941 consisting of $4,000,000 of underwriting commissions, $7,000,000 of deferred underwriting commissions and $587,941 of other cash offering costs. In addition, $1,827,347 of cash was held in the Trust Account (as defined below) temporarily and is available for working capital purposes. Following the closing of the IPO on June 11, 2021, $200,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a Trust Account and, will be held in a U.S.-based trust account (“Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee, and will be invested only in U.S. government treasury bills with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 under the Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its income taxes, if any, the Company’s amended and restated memorandum and articles of association and subject to the requirements of law and regulation, will provide that the proceeds from the IPO and the sale of the Private Placement Warrants held in the Trust Account will not be released from the Trust Account (1) to the Company, until the completion of the initial Business Combination, or (2) to the Company’s public shareholders until the earliest of: (i) the completion of an initial Business Combination, and then only in connection with those Class A ordinary shares that such shareholders properly elected to redeem, (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association, and (iii) the redemption of the Company’s public shares if the Company has not consummated its Business Combination within 24 months from the closing of the IPO, subject to applicable law. The ordinary shares subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $ upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. The Company will have 24 months from the closing of the IPO to complete the initial Business Combination (the “Combination Period”) or during any Extension Period. However, if the Company is unable to complete the initial Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable The Sponsor and the Company’s officers and directors agreed to (i) waive their redemption rights with respect to their Founder Shares in connection with the completion of the initial Business Combination, (ii) waive their redemption rights with respect to their Founder Shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association, (iii) waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares they hold if the Company fails to complete the initial Business Combination within the Combination Period or during any Extension Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete its initial Business Combination within the prescribed timeframe), and (iv) vote any Founder Shares and public shares held by them in favor of the initial Business Combination. The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below the lesser of (i) $10.00 per public share or (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per public share due to reductions in the value of the trust assets, in each case net of the interest that may be withdrawn to pay the Company’s tax obligations, provided that such liability will not apply to any claims by a third party or prospective target business that executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriter of the IPO against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked it Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether its Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure you that the Sponsor would be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. Liquidity and Capital Resources As of September 30, 2021, the Company had approximately $1.08 million of cash for working capital purposes, and working capital of approximately $1.2 million. The Company’s liquidity needs up to September 30, 2021 had been satisfied through a payment from the Sponsor of $25,000 (see Note 6) for the Founder Shares to cover certain offering costs and the loan under an unsecured promissory note from the Sponsor of $300,000 (see Note 6). The promissory note was fully repaid on June 11, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans, as defined below (see Note 6). As of September 30, 2021, there were no amounts outstanding under any Working Capital Loans. Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

Restatement of Prior Period Fin

Restatement of Prior Period Financial Statements	9 Months Ended
	Sep. 30, 2021
Prior Period Adjustment [Abstract]
Restatement of Prior Period Financial Statements	Note 2 — Restatement of Prior Period Financial Statements During the preparation of the unaudited condensed financial statements as of and for the quarterly period ended September 30, 2021, the Company concluded it should classify all Public Shares in temporary equity. In accordance with the SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent equity. In the Company’s previously issued financial statements, a portion of the Public Shares were classified as permanent equity to maintain net tangible assets greater than $5,000,000 on the basis that the Company will consummate its initial Business Combination only if the Company has net tangible assets of at least $5,000,001. Thus, the Company has historically classified a portion of Class A common stock in permanent equity to satisfy the $5,000,000 net tangible asset requirement. Previously, the Company did not consider redeemable stock classified as temporary equity as part of net tangible assets. Effective with these financial statements, the Company revised this interpretation to include temporary equity in net tangible assets. In connection with the change in presentation for the Class A ordinary shares subject to possible redemption, the Company also restated its earnings per share calculation to allocate income and losses shared pro rata between the two classes of shares. This presentation contemplates a Business Combination as the most likely outcome, in which case, both classes of shares share pro rata in the income and losses of the Company. In accordance with SEC Staff Accounting Bulletin No. 99, “Materiality,” and SEC Staff Accounting Bulletin No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements,” the Company evaluated the changes and has determined that the related impact was material to the previously issued (i) audited balance sheet as of June 11, 2021, included in exhibit 99.1 to the Company’s Form 8-K filed with the SEC on June 17, 2021 (the “Form 8-K”) and (ii) unaudited interim financial statements included in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2021, filed with the SEC on August 16, 2021 (together with the Form 8-K, the “Affected Financial Statements”) and such Affected Financial Statements should no longer be relied upon. Therefore, the Company, in consultation with its Audit Committee, concluded that its Affected Financial Statements should be restated to report all Public Shares as temporary equity. As such the Company is reporting these restatements to the Affected Financial Statements in this Quarterly Report on Form 10-Q. The Company’s accounting for the Public Shares as temporary equity instead of permanent equity and allocating income and losses pro rata for each class of its ordinary shares result in non-cash financial statement corrections and will have no impact on the Company’s current or previously reported cash position or total operating, investing or financing cash flows. The impact of the restatement on the audited balance sheet as of June 11, 2021 and unaudited interim financial statements for the period ended June 30, 2021 is presented below: As Previously Adjustments As Restated Balance Sheet at June 11, 2021 Class A ordinary shares, par value; subject to possible redemption at $10.00 per share $ 173,394,700 $ 26,605,300 $ 200,000,000 Class A ordinary shares - $0.0001 par value 266 (266 ) — Additional paid-in 7,835,896 (7,835,896 ) — Accumulated deficit $ (2,836,811 ) $ (18,769,138 ) $ (21,605,949 ) Total shareholders’ equity 5,000,001 (26,605,300 ) (21,605,299 ) Total Liabilities, Class A ordinary shares subject to possible redemption and Shareholders’ (Deficit) Equity 202,189,233 — 202,189,233 Number of shares subject to redemption 17,339,470 2,660,530 20,000,000 Balance Sheet at June 30, 2021 (unaudited) Class A ordinary shares, par value; subject to possible redemption at $10.00 per share $ 171,546,810 $ 28,453,190 $ 200,000,000 Class A ordinary shares - 285 (285 ) — Additional paid-in 9,683,767 (9,683,767 ) — Accumulated deficit $ (4,684,700 ) $ (18,769,138 ) $ (23,453,838 ) Total shareholders’ equity (deficit) 5,000,002 (28,453,190 ) (23,453,188 ) Total Liabilities, Class A ordinary shares subject to possible redemption and Shareholders’ (Deficit) Equity 202,173,211 — 202,173,211 Number of shares subject to redemption 17,154,681 2,845,319 20,000,000 Statement of Operations for the three months ended June 30, 2021 Basic and diluted weighted average shares outstanding of Class A, ordinary shares subject to redemption 20,000,000 (15,604,396 ) 4,395,604 Basic and diluted net income (loss) per share of Class A, ordinary shares subject to redemption $ 0.00 $ (0.46 ) $ (0.46 ) Basic and diluted weighted average shares outstanding of Class B, non-redeemable 5,750,000 — 5,750,000 Basic and diluted net loss per share of Class B, non-redeemable $ (0.81 ) $ 0.35 $ (0.46 ) Statement of Operations for the six months ended June 30, 2021 Basic and diluted weighted average shares outstanding of Class A, ordinary shares subject to redemption $ 20,000,000 $ (17,790,055 ) $ 2,209,945 Basic and diluted net income (loss) per share of Class A, ordinary shares subject to redemption $ — $ (0.59 ) $ (0.59 ) Basic and diluted weighted average shares outstanding of Class B, non-redeemable 5,750,000 — 5,750,000 Basic and diluted net loss per share of Class B, non-redeemable (0.81 ) 0.22 (0.59 ) Statement of Cash Flows for the six months ended June 30, 2021 Initial value of Class A common stock subject to possible redemption 173,394,700 26,605,300 200,000,000 Change in value of Class A common stock subject to possible redemption (1,847,890 ) 1,847,890 —

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Significant Accounting Policies	Note 3 — Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q S-X The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 8-K and the Company’s prospectus for its Initial Public Offering as filed with the SEC on June 17, 2021 and June 10, 2021, respectively. The interim results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods. Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Use of Estimates The preparation of the financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant estimates included in these financial statements is the determination of the fair value of the warrant liability and FPA liability. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have cash equivalents as of September 30, 2021 and December 31, 2020. Investments Held in Trust Account As of September 30, 2021, the assets held in the Trust Account were held in money market fund. The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of days or less, investments in money market funds that invest in U.S. government securities, cash, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on Investments Held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. At September 30, 2021, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Offering Costs Associated with IPO The Company complies with the requirements of the ASC 340-10-S99-1and SEC Staff Accounting Bulletin (“SAB”) Topic 5A“Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Public Offering. Offering costs are charged to ordinary shares subject to possible redemption or the statement of operations based on the relative value of the Public and Private Warrants to the proceeds received from the Units and Private Placement Warrants sold upon the completion of the IPO. Accordingly, on September 30, 2021, offering costs totaling allocated to the Public Warrants and Private Warrants and was charged to operations in accordance with ASC 825-10 and was charged to ordinary shares subject to possible redemption. Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815,“Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued non-current net-cash Warrant Liability and Forward Purchase Agreement The Company accounts for the warrants issued in connection with the IPO (the Public Warrants and the Private Placement Warrants) and Forward Purchase Agreement (“FPA”) in accordance with the guidance contained in FASB ASC 815 “Derivatives and Hedging” whereby under that provision the warrants and FPA do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company will classify warrants and FPA as liabilities at their fair value. These liabilities are subject to re-measurement at each reporting period. With such re-measurement, the changes in fair value are recognized in the Statement of Operations in the period of change. Derivative warrant liabilities and FPA are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. Fair Value Measurements The fair value of the Company’s assets and liabilities, excluding the warrant liability and FPA liability, which qualify as financial instruments under FASB ASC Topic 820, Fair Value Measurement (“ASC 820”), approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at September 30, 2021 and December 31, 2020, 20,000,000 and 0 Class A ordinary shares, respectively, subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. At September 30, 2021, the Class A ordinary shares subject to possible redemption reflected in the condensed balance sheets are reconciled in the following table: Gross proceeds $ 200,000,000 Less: Proceeds allocated to Public Warrants (8,511,409 ) Less: Class A ordinary shares issuance costs (11,080,524 ) Add: Accretion of carrying value to redemption value 19,591,933 Class A ordinary shares subject to possible redemption $ 200,000,000 Net Income (Loss) Per Share of Ordinary Shares The Company has two classes of shares, which are referred to as Class A Ordinary Shares and Class B Ordinary Shares. Earnings and losses are shared pro rata between the two classes of shares. The 16,000,000 potential common shares for outstanding warrants to purchase the Company’s stock were excluded from diluted earnings per share for the three and nine months ended September 30, 2021 because the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net income per common share is the same as basic net income per common share for the periods. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares: For the Three Months Ended For the Nine Months ended Class A Class B Class A Class B Basic and diluted net income per share: Numerator: Allocation of net income (loss) $ 803,726 $ 231,071 $ (2,143,878 ) $ (1,502,389 ) Denominator: Weighted-average shares outstanding 20,000,000 5,750,000 8,205,128 5,750,000 Basic and diluted net income (loss) per share $ 0.04 $ 0.04 $ (0.26 ) $ (0.26 ) Income Taxes ASC 740 clarifies the accounting for uncertainty in income taxes recognized in a Company’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statement. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Recent Accounting Pronouncements In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, 470-20) 815-40) 2020-06”) 2020-06 2020-06 if-converted 2020-06 Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would hav.e a material effect on the Company’s financial statements.

Initial Public Offering

Initial Public Offering	9 Months Ended
	Sep. 30, 2021
Stockholders' Equity Note [Abstract]
Initial Public Offering	Note 4 — Initial Public Offering On June 11, 2021, the Company consummated its IPO of 20,000,000 Units (the “Units”), at a price of $10.00 per unit, generating gross proceeds to the Company of $200,000,000. Each Unit consists of one Class A ordinary share and one-half of one

Private Placement

Private Placement	9 Months Ended
	Sep. 30, 2021
Private Placement Warrants [Abstract]
Private Placement	Note 5 — Private Placement Simultaneously with the closing of the IPO and the sale of the Units, the Company consummated the private placement (“Private Placement”) of an aggregate 6,000,000 Private Placement Warrants (“Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $6,000,000. If the Company does not complete an initial Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable by the If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the units being sold in the IPO.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Note 6 — Related Party Transactions Founder Shares On December 31, 2020, the Company issued to the Sponsor 5,750,000 Class B ordinary shares, par value $0.0001 (the “Founder Shares”), for $25,000 for certain expenses on behalf of the Company, or approximately $0.004 per share. On April 30, 2021, the Company effected a share capitalization, pursuant to which the Company’s initial shareholders held an aggregate of 6,500,000 Class B ordinary shares. The accompanying financial statements have been retroactively adjusted to reflect the stock dividend in the share capitalization. On April 30, 2021, the Company entered into forward purchase agreements (see Note 7) with anchor investors, in connection with entering into the forward purchase agreements, the Sponsor transferred to the anchor investors an aggregate of 375,000 Class B ordinary shares for no cash. On April 30, 2021, the Sponsor transferred 25,000 Class B ordinary shares each to three independent director nominees. Up to 750,000 Founder Shares were subject to forfeiture by the Sponsor depending on the extent to which the underwriters’ over-allotment option is exercised. On July 23, 2021, the Sponsor surrendered 750,000 Founder Shares, with no return of capital or payment by the Sponsor, after the expiration of the unexercised underwriters’ over-allotment option. As a result of the foregoing, at September 30, 2021 and December 31, 2020, the Sponsor owned 5,300,000 and 6,500,000 Class B ordinary shares, respectively. The Sponsor within any 30-trading day period property (the “Lock-up”). Any permitted Promissory Note — Related Party The Sponsor has agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the IPO. These loans were non-interest Related Party Loans In addition, in order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes the initial Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants. As of September 30, 2021 and December 31, 2020, the Company had no borrowings under the Working Capital Loans. Administrative Service Fee Commencing on the Effective Date, the Company will pay an affiliate of the Sponsor $10,000 per month for office space, utilities, administrative services and remote support services. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. The Company incurred $30,000 for the administrative service fee for the three and nine months ended September 30, 2021.

Recurring Fair Value Measuremen

Recurring Fair Value Measurements	9 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Recurring Fair Value Measurements	Note 7 — Recurring Fair Value Measurements Warrant Liability and FPA Liability At September 30, 2021, the Company’s Warrant liability was valued at $13,800,974, and FPA liability was valued at $2,807,021. Under the guidance in ASC 815-40 re-measurement re-measurement, Recurring Fair Value Measurements The following table presents fair value information as of September 30, 2021 of the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. The Company’s Warrant liability is based on a valuation models utilizing management judgment and pricing inputs from observable and unobservable markets with less volume and transaction frequency than active markets. Significant deviations from these estimates and inputs could result in a material change in fair value. The fair value of the Warrant liability and FPA liability is classified within Level 3 of the fair value hierarchy. The investments held in Trust Account includes money market funds. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its level 1 investments. The following table sets forth by level within the fair value hierarchy the Company’s assets and liabilities as of September , , that were accounted for at fair value on a recurring basis: (Level 1) (Level 2) (Level 3) Investments held in Trust Account $ 200,003,049 $ — $ — Liabilities Public Warrants $ 8,601,000 $ — $ — Private Warrants $ — $ — $ 5,199,974 FPA liability $ — $ — $ 2,807,021 Measurement Warrants The Company established the initial fair value for the Warrants on June 11, 2021, the date of the consummation of the Company’s IPO. The Company used a Monte Carlo simulation model to value the Warrants. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one Class A ordinary share and one-half The key inputs for the valuation of Public and Private Warrants are as follows: Input June 11, 2021 September 30, 2021 Volatility 16.30 % 17.8 % Risk Free Rate 0.89 % 1.04 % Stock Price $ 9.5746 9.7500 Est. Term Remaining (Yrs) 5.65 5.35 To arrive the conclusion of Fair Value of the Forward Purchase Agreements, the Company analyzed the agreements and other documentation. The Company utilized the underlying shares and warrant values determined above and the following inputs in order to project the net asset or liability value of the FPA: Input June 11, 2021 September 30, 2021 Volatility 16.30 % 17.8 % Stock Price $ 9.5746 9.7500 Warrant Price $ 0.851 0.860 Est. Term to Business Combination (Yrs) 0.65 0.35 Probability of Business Combination 85 % 85 % Purchase price of FPA unit $ 10.00 10.00 The following table provides a reconciliation of changes in fair value of the beginning and ending balances of the Company’s FPA liability classified as level 3: FPA liability Fair value at January 1, 2021 $ — Initial value at IPO date 2,322,741 Change in fair value 484,280 Fair Value at September 30, 2021 $ 2,807,021 Transfers between levels of the fair value hierarchy are recognized at the end of the reporting period.

Commitments & Contingencies

Commitments & Contingencies	9 Months Ended
	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments & Contingencies	Note 8 — Commitments & Contingencies Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic on Registration Rights The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) will be entitled to registration rights pursuant to a registration and shareholder rights agreement to be signed prior to or on the effective date of the IPO. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of its initial Business Combination. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable Lock-up period, which Underwriters Agreement The underwriters have a 45-day option to if any. The over-allotment option expired unexercised on July 23, 2021. The underwriters were paid are Forward Purchase Agreements On April 30, 2021, the Company entered into forward purchase agreements with the Sponsor, Snow Lake Capital (HK) Limited and Valliance Fund (the “anchor investors”), pursuant to which the anchor investors agreed to subscribe for an aggregate of 3,000,000 Class A ordinary shares plus 750,000 redeemable warrants for a purchase price of $10.00 multiplied by the number of Class A ordinary shares, or $30,000,000 in the aggregate, in a private placement to close concurrently with the closing of the initial business combination. The Company issued 750,000 additional Class B ordinary shares to the Sponsor, which represent the adjustment to the ratio applicable to the conversion of the Class B ordinary shares that the Sponsor would have been entitled to at the closing of the initial business combination as a result of the issuance of 3,000,000 additional Class A ordinary shares under the forward purchase agreements. As a result, the issuance of the Class A ordinary shares at the closing of the initial business combination will not trigger a further adjustment to this ratio. Further, prior to the IPO, the Sponsor transferred to the anchor investors an aggregate of 375,000 Founder Shares for no cash consideration. Subject to certain exceptions to forfeiture and transfer provisions, the Founder Shares transferred in connection with these agreements are subject to similar contractual conditions and restrictions as the Founder Shares issued to the Sponsor in connection with the IPO. The forward purchase warrants will have the same terms as the public warrants. The forward purchase agreements provide that the anchor investors are entitled to registration rights with respect to the forward purchase securities and Class A ordinary shares underlying the forward purchase warrants and founder shares. The proceeds from the sale of the forward purchase securities may be used as part of the consideration to the sellers in the initial Business Combination, expenses in connection with the initial Business Combination or for working capital in the post Business Combination company. These purchases will be required to be made regardless of whether any Class A ordinary shares are redeemed by the public shareholders and are intended to provide the Company with a minimum funding level for the initial Business Combination. The anchor investors will not have the ability to approve the initial Business Combination prior to the signing of a material definitive agreement and, if the Company seeks shareholder approval, have agreed to vote their Founder Shares and any public shares held by them in favor of the initial Business Combination. The forward purchase securities will be issued only in connection with the closing of the initial Business Combination.

Warrant Liability

Warrant Liability	9 Months Ended
	Sep. 30, 2021
Warrant Liability [Abstract]
Warrant Liability	Note 9 — Warrant Liability A s of September 30, . Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00. Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants): • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and • if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within a 30-trading day The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemptionperiod. Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00 . Once the warrants become exercisable, the Company may redeem the outstanding warrants: • in whole and not in part; • at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table below, based on the redemption date and the “fair market value” of the Class A ordinary shares; • if, and only if, the closing price of our Class A ordinary shares equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within the 30-trading day • if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading day In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connectio with the closing of the initial Business Combination at an issue price or effective issue price of less than $ per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and in the case of any such issuance to the Company’s Sponsors or its affiliate, without taking into account any Founder Shares held by the Company’s Sponsor or such affiliates, as applicable, prior to such issuance (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than % of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the completion of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A ordinary shares during the trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $ per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to % of the higher of the Market Value and the Newly Issued Price, and the $ per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to % of the higher of the Market Value and the Newly Issued Price, and the $ per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.

Shareholders' (Deficit) Equity

Shareholders' (Deficit) Equity	9 Months Ended
	Sep. 30, 2021
Stockholders' Equity Note [Abstract]
Shareholders' (Deficit) Equity	Note 10 — Shareholders’ (Deficit) Equity Preference shares The Company is authorized to issue 5,000,000 preference shares with a par value of $0.0001 and with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2021 and December 30, 2020, there were no preference shares issued or outstanding. Class A Ordinary Shares The Company is authorized to issue 500,000,000 Class A ordinary shares with a par value of $0.0001 per share. As of December 31, 2020, 0 Class A ordinary shares issued or outstanding. There were Class A ordinary shares issued and outstanding, including the 20,000,000 shares presented in ordinary shares subject to redemption as September 30, 2021. Class B Ordinary Shares The Company is authorized to issue 50,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders are entitled to one vote for each share of Class B ordinary shares. As of September 30, 2021 and December 31, 2020, there were 5,750,000 and 6,500,000 Class B ordinary shares issued and outstanding, respectively. Of the 6,500,000 Class B ordinary shares, an aggregate of up to 750,000 shares were subject to forfeiture to the Company for no consideration to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the initial shareholders will collectively own 20% of the Company’s issued and outstanding ordinary shares after the IPO. On July 23, 2021, the Sponsor surrendered 750,000 Founder Shares, with no return of capital or payment by the Sponsor, after the expiration of the unexercised underwriters’ over-allotment option. Class A ordinary shareholders and Class B ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders and vote together as a single class, except as required by law. Prior to the initial Business Combination, only holders of the Founder Shares will have the right to vote on the election of directors. Holders of the public shares will not be entitled to vote on the appointment of directors during such time. In addition, prior to the completion of an initial Business Combination, holders of a majority of the Founder Shares may remove a member of the board of directors for any reason. The Class B ordinary shares will automatically convert into Class A ordinary shares (which such Class A ordinary shares delivered upon conversion will not have redemption rights or be entitled to liquidating distributions from the Trust Account if the Company does not consummate an initial Business Combination) at the time of the initial Business Combination or earlier at the option of the holders thereof at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20%of less than

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	Note 11 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based on this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statement.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q S-X The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 8-K and the Company’s prospectus for its Initial Public Offering as filed with the SEC on June 17, 2021 and June 10, 2021, respectively. The interim results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods.
Emerging Growth Company Status	Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
Use of Estimates	Use of Estimates The preparation of the financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant estimates included in these financial statements is the determination of the fair value of the warrant liability and FPA liability.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have cash equivalents as of September 30, 2021 and December 31, 2020.
Investments Held in Trust Account	Investments Held in Trust Account As of September 30, 2021, the assets held in the Trust Account were held in money market fund. The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of days or less, investments in money market funds that invest in U.S. government securities, cash, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on Investments Held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. At September 30, 2021, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Due to Related Party	Offering Costs Associated with IPO
Offering Costs Associated with IPO	The Company complies with the requirements of the ASC 340-10-S99-1and SEC Staff Accounting Bulletin (“SAB”) Topic 5A“Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Public Offering. Offering costs are charged to ordinary shares subject to possible redemption or the statement of operations based on the relative value of the Public and Private Warrants to the proceeds received from the Units and Private Placement Warrants sold upon the completion of the IPO. Accordingly, on September 30, 2021, offering costs totaling allocated to the Public Warrants and Private Warrants and was charged to operations in accordance with ASC 825-10 and was charged to ordinary shares subject to possible redemption.
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815,“Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued non-current net-cash
Warrant Liability and Forward Purchase Agreement	Warrant Liability and Forward Purchase Agreement The Company accounts for the warrants issued in connection with the IPO (the Public Warrants and the Private Placement Warrants) and Forward Purchase Agreement (“FPA”) in accordance with the guidance contained in FASB ASC 815 “Derivatives and Hedging” whereby under that provision the warrants and FPA do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company will classify warrants and FPA as liabilities at their fair value. These liabilities are subject to re-measurement at each reporting period. With such re-measurement, the changes in fair value are recognized in the Statement of Operations in the period of change. Derivative warrant liabilities and FPA are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Fair Value Measurements	Fair Value Measurements The fair value of the Company’s assets and liabilities, excluding the warrant liability and FPA liability, which qualify as financial instruments under FASB ASC Topic 820, Fair Value Measurement (“ASC 820”), approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at September 30, 2021 and December 31, 2020, 20,000,000 and 0 Class A ordinary shares, respectively, subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. At September 30, 2021, the Class A ordinary shares subject to possible redemption reflected in the condensed balance sheets are reconciled in the following table: Gross proceeds $ 200,000,000 Less: Proceeds allocated to Public Warrants (8,511,409 ) Less: Class A ordinary shares issuance costs (11,080,524 ) Add: Accretion of carrying value to redemption value 19,591,933 Class A ordinary shares subject to possible redemption $ 200,000,000
Net Income (Loss) Per Share of Ordinary Shares	Net Income (Loss) Per Share of Ordinary Shares The Company has two classes of shares, which are referred to as Class A Ordinary Shares and Class B Ordinary Shares. Earnings and losses are shared pro rata between the two classes of shares. The 16,000,000 potential common shares for outstanding warrants to purchase the Company’s stock were excluded from diluted earnings per share for the three and nine months ended September 30, 2021 because the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net income per common share is the same as basic net income per common share for the periods. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares: For the Three Months Ended For the Nine Months ended Class A Class B Class A Class B Basic and diluted net income per share: Numerator: Allocation of net income (loss) $ 803,726 $ 231,071 $ (2,143,878 ) $ (1,502,389 ) Denominator: Weighted-average shares outstanding 20,000,000 5,750,000 8,205,128 5,750,000 Basic and diluted net income (loss) per share $ 0.04 $ 0.04 $ (0.26 ) $ (0.26 )
Income Taxes	Income Taxes ASC 740 clarifies the accounting for uncertainty in income taxes recognized in a Company’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statement. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, 470-20) 815-40) 2020-06”) 2020-06 2020-06 if-converted 2020-06 Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would hav.e a material effect on the Company’s financial statements.

Restatement of Prior Period F_2

Restatement of Prior Period Financial Statements (Tables)	9 Months Ended
	Sep. 30, 2021
Prior Period Adjustment [Abstract]
Summary of impact of revision on audited balance sheet	The impact of the restatement on the audited balance sheet as of June 11, 2021 and unaudited interim financial statements for the period ended June 30, 2021 is presented below: As Previously Adjustments As Restated Balance Sheet at June 11, 2021 Class A ordinary shares, par value; subject to possible redemption at $10.00 per share $ 173,394,700 $ 26,605,300 $ 200,000,000 Class A ordinary shares - $0.0001 par value 266 (266 ) — Additional paid-in 7,835,896 (7,835,896 ) — Accumulated deficit $ (2,836,811 ) $ (18,769,138 ) $ (21,605,949 ) Total shareholders’ equity 5,000,001 (26,605,300 ) (21,605,299 ) Total Liabilities, Class A ordinary shares subject to possible redemption and Shareholders’ (Deficit) Equity 202,189,233 — 202,189,233 Number of shares subject to redemption 17,339,470 2,660,530 20,000,000 Balance Sheet at June 30, 2021 (unaudited) Class A ordinary shares, par value; subject to possible redemption at $10.00 per share $ 171,546,810 $ 28,453,190 $ 200,000,000 Class A ordinary shares - 285 (285 ) — Additional paid-in 9,683,767 (9,683,767 ) — Accumulated deficit $ (4,684,700 ) $ (18,769,138 ) $ (23,453,838 ) Total shareholders’ equity (deficit) 5,000,002 (28,453,190 ) (23,453,188 ) Total Liabilities, Class A ordinary shares subject to possible redemption and Shareholders’ (Deficit) Equity 202,173,211 — 202,173,211 Number of shares subject to redemption 17,154,681 2,845,319 20,000,000 Statement of Operations for the three months ended June 30, 2021 Basic and diluted weighted average shares outstanding of Class A, ordinary shares subject to redemption 20,000,000 (15,604,396 ) 4,395,604 Basic and diluted net income (loss) per share of Class A, ordinary shares subject to redemption $ 0.00 $ (0.46 ) $ (0.46 ) Basic and diluted weighted average shares outstanding of Class B, non-redeemable 5,750,000 — 5,750,000 Basic and diluted net loss per share of Class B, non-redeemable $ (0.81 ) $ 0.35 $ (0.46 ) Statement of Operations for the six months ended June 30, 2021 Basic and diluted weighted average shares outstanding of Class A, ordinary shares subject to redemption $ 20,000,000 $ (17,790,055 ) $ 2,209,945 Basic and diluted net income (loss) per share of Class A, ordinary shares subject to redemption $ — $ (0.59 ) $ (0.59 ) Basic and diluted weighted average shares outstanding of Class B, non-redeemable 5,750,000 — 5,750,000 Basic and diluted net loss per share of Class B, non-redeemable (0.81 ) 0.22 (0.59 ) Statement of Cash Flows for the six months ended June 30, 2021 Initial value of Class A common stock subject to possible redemption 173,394,700 26,605,300 200,000,000 Change in value of Class A common stock subject to possible redemption (1,847,890 ) 1,847,890 —

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Summary of basic and diluted net income (loss) per common share	The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares: For the Three Months Ended For the Nine Months ended Class A Class B Class A Class B Basic and diluted net income per share: Numerator: Allocation of net income (loss) $ 803,726 $ 231,071 $ (2,143,878 ) $ (1,502,389 ) Denominator: Weighted-average shares outstanding 20,000,000 5,750,000 8,205,128 5,750,000 Basic and diluted net income (loss) per share $ 0.04 $ 0.04 $ (0.26 ) $ (0.26 )
Summary of Class A ordinary shares subject to possible redemption	At September 30, 2021, the Class A ordinary shares subject to possible redemption reflected in the condensed balance sheets are reconciled in the following table: Gross proceeds $ 200,000,000 Less: Proceeds allocated to Public Warrants (8,511,409 ) Less: Class A ordinary shares issuance costs (11,080,524 ) Add: Accretion of carrying value to redemption value 19,591,933 Class A ordinary shares subject to possible redemption $ 200,000,000

Recurring Fair Value Measurem_2

Recurring Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2021
Summary of Fair Value Hierarchy the Company's Assets and Liabilities	(Level 1) (Level 2) (Level 3) Investments held in Trust Account $ 200,003,049 $ — $ — Liabilities Public Warrants $ 8,601,000 $ — $ — Private Warrants $ — $ — $ 5,199,974 FPA liability $ — $ — $ 2,807,021
Public and Private Warrants
Summary of Valuation of Public and Private Warrants	The key inputs for the valuation of Public and Private Warrants are as follows: Input June 11, 2021 September 30, 2021 Volatility 16.30 % 17.8 % Risk Free Rate 0.89 % 1.04 % Stock Price $ 9.5746 9.7500 Est. Term Remaining (Yrs) 5.65 5.35
FPA liability
Summary of Valuation of Public and Private Warrants	To arrive the conclusion of Fair Value of the Forward Purchase Agreements, the Company analyzed the agreements and other documentation. The Company utilized the underlying shares and warrant values determined above and the following inputs in order to project the net asset or liability value of the FPA: Input June 11, 2021 September 30, 2021 Volatility 16.30 % 17.8 % Stock Price $ 9.5746 9.7500 Warrant Price $ 0.851 0.860 Est. Term to Business Combination (Yrs) 0.65 0.35 Probability of Business Combination 85 % 85 % Purchase price of FPA unit $ 10.00 10.00
Summary of reconciliation of changes in fair value of derivative warrant liabilities	The following table provides a reconciliation of changes in fair value of the beginning and ending balances of the Company’s FPA liability classified as level 3: FPA liability Fair value at January 1, 2021 $ — Initial value at IPO date 2,322,741 Change in fair value 484,280 Fair Value at September 30, 2021 $ 2,807,021
Derivative Warrant Liabilities [Member]
Summary of reconciliation of changes in fair value of derivative warrant liabilities	The following table provides a reconciliation of changes in fair value of the beginning and ending balances of the Company’s derivative warrant liabilities classified as level 3: Derivative Fair value at January 1, 2021 $ — Initial value at IPO date 13,712,964 Change in fair value 88,010 Transfer of Public warrants from level 3 to level 1 (8,601,000 ) Fair Value at September 30, 2021 $ 5,199,974

Organization, Business Operat_2

Organization, Business Operation and Going Concern Consideration - Additional information (Detail) - USD ($)	Jun. 11, 2021	Apr. 30, 2021	Sep. 30, 2021	Jun. 30, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Shares issued, price per share			$ 10
Proceeds from issuance initial public offering			$ 196,000,000
Class of warrants and rights issued during the period			16,000,000
Proceeds from issuance of private placement			$ 6,000,000
Deferred underwriting commissions noncurrent			7,000,000
Minimum net worth required for compliance			5,000,001
Cash			1,075,137
Working capital (deficit)			1,200,000
Proceeds from unsecured notes payable			300,000
Working capital loans			$ 0
Forecast
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Dissolution expense				$ 100,000
Private Placement Warrants
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Class of warrants and rights issued during the period			6,000,000
Sponsor
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Proceeds from issuance of common stock			$ 25,000
Sponsor | Private Placement Warrants
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Class of warrants and rights issued during the period			6,000,000
Class of warrants and rights issued, price per warrant			$ 1
Proceeds from issuance of private placement			$ 6,000,000
IPO
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Shares issued, price per share	$ 10
Proceeds from issuance initial public offering	$ 200,000,000		200,000,000
Payments for underwriting expense			4,000,000
Deferred underwriting commissions noncurrent			7,000,000
Other offering costs			587,941
Payments to acquire restricted certificates of deposit			1,827,347
Stock issuance costs			$ 11,587,941
Common Class A | Sponsor
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Proceeds from issuance of common stock		$ 30,000,000
Common Class A | IPO
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during period, shares, new issues	20,000,000
Shares issued, price per share	$ 10
Proceeds from issuance initial public offering	$ 200,000,000

Restatement of Prior Period F_3

Restatement of Prior Period Financial Statements - Summary of Impact of Revision on Audited Balance Sheet (Detail) - USD ($)	3 Months Ended		6 Months Ended	9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Jun. 30, 2021	Sep. 30, 2021	Jun. 11, 2021	Dec. 31, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption	$ 200,000,000	$ 200,000,000	$ 200,000,000	$ 200,000,000	$ 200,000,000
Additional paid-in capital		0	0		0	$ 24,350
Accumulated deficit	(22,418,966)	(23,453,838)	(23,453,838)	(22,418,966)	(21,605,949)	(3,636)
Total shareholders' equity	(22,418,391)	(23,453,188)	(23,453,188)	(22,418,391)	(21,605,299)	21,364
Total Liabilities, Class A ordinary shares subject to possible redemption and Shareholders' (Deficit) Equity	201,299,890	$ 202,173,211	$ 202,173,211	201,299,890	$ 202,189,233	91,374
Number of shares subject to redemption		20,000,000	20,000,000		20,000,000
Initial value of Class A common stock subject to possible redemption			$ 200,000,000
Change in value of Class A common stock subject to possible redemption			$ 0
Class A Ordinary Shares Subject To Redemption [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Basic and diluted weighted average shares outstanding		4,395,604	2,209,945
Basic and diluted net income (loss) per ordinary shares		$ (0.46)	$ (0.59)
Class B Non-redeemable Ordinary Shares [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Basic and diluted weighted average shares outstanding		5,750,000	5,750,000
Basic and diluted net income (loss) per ordinary shares		$ (0.46)	$ (0.59)
Common Class A
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption	200,000,000			200,000,000
Common Stock	0	$ 0	$ 0	0	$ 0
Total shareholders' equity	$ 0	0	0	$ 0		$ 0
Number of shares subject to redemption	20,000,000			20,000,000		0
Basic and diluted weighted average shares outstanding	20,000,000			8,205,128
Basic and diluted net income (loss) per ordinary shares	$ 0.04			$ (0.26)
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption		171,546,810	171,546,810		173,394,700
Additional paid-in capital		9,683,767	9,683,767		7,835,896
Accumulated deficit		(4,684,700)	(4,684,700)		(2,836,811)
Total shareholders' equity		5,000,002	5,000,002		5,000,001
Total Liabilities, Class A ordinary shares subject to possible redemption and Shareholders' (Deficit) Equity		$ 202,173,211	$ 202,173,211		$ 202,189,233
Number of shares subject to redemption		17,154,681	17,154,681		17,339,470
Initial value of Class A common stock subject to possible redemption			$ 173,394,700
Change in value of Class A common stock subject to possible redemption			$ (1,847,890)
As Previously Reported | Class A Ordinary Shares Subject To Redemption [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Basic and diluted weighted average shares outstanding		20,000,000	20,000,000
Basic and diluted net income (loss) per ordinary shares		$ 0
As Previously Reported | Class B Non-redeemable Ordinary Shares [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Basic and diluted weighted average shares outstanding		5,750,000	5,750,000
Basic and diluted net income (loss) per ordinary shares		$ (0.81)	$ (0.81)
As Previously Reported | Common Class A
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common Stock		$ 285	$ 285		$ 266
Adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption		28,453,190	28,453,190		26,605,300
Additional paid-in capital		(9,683,767)	(9,683,767)		(7,835,896)
Accumulated deficit		(18,769,138)	(18,769,138)		(18,769,138)
Total shareholders' equity		(28,453,190)	(28,453,190)		(26,605,300)
Total Liabilities, Class A ordinary shares subject to possible redemption and Shareholders' (Deficit) Equity		$ 0	$ 0		$ 0
Number of shares subject to redemption		2,845,319	2,845,319		2,660,530
Initial value of Class A common stock subject to possible redemption			$ 26,605,300
Change in value of Class A common stock subject to possible redemption			$ 1,847,890
Adjustments | Class A Ordinary Shares Subject To Redemption [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Basic and diluted weighted average shares outstanding		(15,604,396)	(17,790,055)
Basic and diluted net income (loss) per ordinary shares		$ (0.46)	$ (0.59)
Adjustments | Class B Non-redeemable Ordinary Shares [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Basic and diluted net income (loss) per ordinary shares		$ 0.35	$ 0.22
Adjustments | Common Class A
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common Stock		$ (285)	$ (285)		$ (266)

Restatement of Prior Period F_4

Restatement of Prior Period Financial Statements - Summary of Impact of Revision on Audited Balance Sheet (Parenthetical) (Detail) - Common Class A - $ / shares	Sep. 30, 2021	Jun. 30, 2021	Jun. 11, 2021	Dec. 31, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Temporary Equity, Par or Stated Value Per Share	$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
Common stock par or stated value per share	0.0001	0.0001	0.0001	0.0001
Temporary Equity, Redemption Price Per Share	$ 10	10	10	$ 10
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Temporary Equity, Par or Stated Value Per Share		0.0001	0.0001
Common stock par or stated value per share		0.0001	0.0001
Temporary Equity, Redemption Price Per Share		10	10
Adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Temporary Equity, Par or Stated Value Per Share		0.0001	0.0001
Common stock par or stated value per share		0.0001	0.0001
Temporary Equity, Redemption Price Per Share		$ 10	$ 10

Restatement of Prior Period F_5

Restatement of Prior Period Financial Statements - Additional Information (Detail)	Sep. 30, 2021USD ($)
Prior Period Adjustment [Abstract]
Minimum net tangible assets required to consummate initial business combination	$ 5,000,000
Minimum net worth required for compliance	$ 5,000,001

Significant Accounting Polici_4

Significant Accounting Policies - Additional information (Detail) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021	Jun. 30, 2021	Jun. 11, 2021	Dec. 31, 2020
Cash Equivalents	$ 0	$ 0			$ 0
FDIC insured amount	250,000	250,000
Deferred underwriting commissions	$ 7,000,000	7,000,000
Offering costs charged to the shareholders' equity		$ 11,080,524
Class of warrants and rights issued during the period		16,000,000
Temporary equity, shares outstanding			20,000,000	20,000,000
Warrant
Antidilutive securities excluded from computation of earnings per share, Amount	16,000,000	16,000,000
US Government Securities [Member]
Restricted Investments Term		185 days
IPO
Stock issuance costs		$ 11,587,941
Payments for underwriting expense		4,000,000
Deferred underwriting commissions	$ 7,000,000	7,000,000
Other offering costs		587,941
Public Warrants And Private Warrants | IPO
Other offering costs		$ 587,941
Private Placement Warrants
Class of warrants and rights issued during the period		6,000,000
Public Warrants
Class of warrants and rights issued during the period		10,000,000
Common Class A
Offering costs charged to the shareholders' equity		$ 11,080,524
Temporary equity, shares outstanding	20,000,000	20,000,000			0

Significant Accounting Polici_5

Significant Accounting Policies - Summary of Basic and Diluted Net Income (Loss) Per Common Share (Detail) - USD ($)	3 Months Ended	6 Months Ended	9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Sep. 30, 2021
Class of Stock [Line Items]
Allocation of net income (loss)	$ 1,034,797	$ (4,681,064)	$ (3,646,267)
Common Class A
Class of Stock [Line Items]
Allocation of net income (loss)	$ 803,726		$ (2,143,878)
Weighted-average shares outstanding	20,000,000		8,205,128
Basic and diluted net income (loss) per share	$ 0.04		$ (0.26)
Common Class B
Class of Stock [Line Items]
Allocation of net income (loss)	$ 231,071		$ (1,502,389)
Weighted-average shares outstanding	5,750,000		5,750,000
Basic and diluted net income (loss) per share	$ 0.04		$ (0.26)

Significant Accounting Polici_6

Significant Accounting Policies - Summary of Class A ordinary shares subject to possible redemption (Detail) - USD ($)	Jun. 11, 2021	Jun. 30, 2021	Sep. 30, 2021
Temporary Equity [Line Items]
Gross proceeds			$ 196,000,000
Less: Class A ordinary shares issuance costs			(11,080,524)
Add: Accretion of carrying value to redemption value		$ 19,591,933
Class A ordinary shares subject to possible redemption	$ 200,000,000	$ 200,000,000	200,000,000
Common Class A [Member]
Temporary Equity [Line Items]
Less: Class A ordinary shares issuance costs			(11,080,524)
Add: Accretion of carrying value to redemption value			19,591,933
Class A ordinary shares subject to possible redemption			200,000,000
IPO [Member]
Temporary Equity [Line Items]
Gross proceeds	200,000,000		200,000,000
Less: Proceeds allocated to Public Warrants			$ (8,511,409)
IPO [Member] | Common Class A [Member]
Temporary Equity [Line Items]
Gross proceeds	$ 200,000,000

Initial Public Offering - Addit

Initial Public Offering - Additional Information (Detail) - USD ($)	Jun. 11, 2021	Sep. 30, 2021
Shares issued, price per share		$ 10
Proceeds from issuance initial public offering		$ 196,000,000
Class of warrant or right, threshold period for exercise from date of closing public offering		12 months
Class of warrant or right redemption threshold consecutive trading days		30 days
IPO
Shares issued, price per share	$ 10
Proceeds from issuance initial public offering	$ 200,000,000	$ 200,000,000
Common Class A | IPO
Stock shares issued during the period shares	20,000,000
Shares issued, price per share	$ 10
Proceeds from issuance initial public offering	$ 200,000,000

Private Placement - Additional

Private Placement - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2021USD ($)$ / sharesshares
Private Placement [Line Items]
Class of warrants and rights issued during the period	16,000,000
Proceeds from private placement | $	$ 6,000,000
Private Placement Warrants
Private Placement [Line Items]
Class of warrants and rights issued during the period	6,000,000
Sponsor | Private Placement Warrants
Private Placement [Line Items]
Class of warrants and rights issued during the period	6,000,000
Class of warrants and rights issued, price per warrant | $ / shares	$ 1
Proceeds from private placement | $	$ 6,000,000

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail)	Sep. 30, 2021USD ($)$ / sharesshares	Apr. 30, 2021USD ($)Nomineesshares	Dec. 31, 2020USD ($)$ / sharesshares	Sep. 30, 2021USD ($)$ / sharesshares	Sep. 30, 2021USD ($)$ / sharesshares
Related Party Transaction [Line Items]
Offering proceeds allocated to payment of offering expenses					$ 1,000,000
Proceeds from issuance of debt					140,068
Note payable – related party	$ 0		$ 5,010	$ 0	0
Due to related parties	$ 37,667			$ 37,667	$ 37,667
Working Capital Loan
Related Party Transaction [Line Items]
Warrants issued price per warrant | $ / shares	$ 1			$ 1	$ 1
Due to related parties	$ 0		$ 0	$ 0	$ 0
Working capital loans convertible into warrants	1,500,000			1,500,000	1,500,000
Administrative Service Fee
Related Party Transaction [Line Items]
Due to related parties	37,667			37,667	37,667
Expenses from transactions with related party	10,000			30,000	30,000
Sponsor
Related Party Transaction [Line Items]
Proceeds from issuance of common stock					25,000
Sponsor | Promissory Note
Related Party Transaction [Line Items]
Debt instrument, face amount	$ 300,000			$ 300,000	$ 300,000
Sponsor | Founder shares
Related Party Transaction [Line Items]
Class B ordinary share issued to initial shareholders, shares | shares		25,000
Sponsor | Founder shares | Director
Related Party Transaction [Line Items]
Number of independent director nominees | Nominees		3
Common Class B
Related Party Transaction [Line Items]
Common stock par or stated value per share | $ / shares	$ 0.0001		$ 0.0001	$ 0.0001	$ 0.0001
Common stock shares outstanding | shares	5,750,000		6,500,000	5,750,000	5,750,000
Common Class B | Sponsor
Related Party Transaction [Line Items]
Common stock par or stated value per share | $ / shares	$ 0.0001			$ 0.0001	$ 0.0001
Stock issued during period, value, issued for services			$ 25,000
Proceeds from sponsor to cover certain offering costs per share value | $ / shares			$ 0.004
Common stock shares outstanding | shares	5,750,000	6,500,000	6,500,000	5,750,000	5,750,000
Class B ordinary share issued to initial shareholders, shares | shares		750,000	5,750,000
Share price | $ / shares	$ 12			$ 12	$ 12
Number of trading days for determining the share price					20 days
Number of consecutive trading days for determining the share price					30 days
Waiting period after which the share trading days are considered					150 days
Common Class B | Sponsor | Founder shares
Related Party Transaction [Line Items]
Common stock shares outstanding | shares	5,300,000		6,500,000	5,300,000	5,300,000
Common stock shares subject to forfeiture | shares					750,000
Common Class B | Anchor investors
Related Party Transaction [Line Items]
Class B ordinary share issued to initial shareholders, shares | shares		375,000
Proceeds from issuance of common stock		$ 0
Common Class B | Anchor investors | Founder shares
Related Party Transaction [Line Items]
Class B ordinary share issued to initial shareholders, shares | shares		375,000
Proceeds from issuance of common stock		$ 0

Recurring Fair Value Measurem_3

Recurring Fair Value Measurements - Summary of Fair Value Hierarchy the Company's Assets and Liabilities (Detail)	Sep. 30, 2021USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant Liability	$ 13,800,974
FPA liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant Liability	2,807,021
Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments held in Trust Account	200,003,049
Fair Value, Recurring | Public Warrants | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant Liability	8,601,000
Fair Value, Recurring | Public Warrants | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant Liability	0
Fair Value, Recurring | Private Warrants | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant Liability	5,199,974
Fair Value, Recurring | FPA liability | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant Liability	$ 2,807,021

Recurring Fair Value Measurem_4

Recurring Fair Value Measurements - Summary of Valuation of Public and Private Warrants (Detail) - Public and Private Warrants	Sep. 30, 2021$ / sharesyr	Jun. 11, 2021yr$ / shares
Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	17.8	16.30
Risk Free Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	1.04	0.89
Stock Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input | $ / shares	9.7500	9.5746
Est. Term Remaining (Yrs)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input | yr	5.35	5.65

Recurring Fair Value Measurem_5

Recurring Fair Value Measurements - Summary of Valuation of Public and Private Warrants of FPA (Detail) - FPA liability	Sep. 30, 2021yr$ / shares	Jun. 11, 2021$ / sharesyr
Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	17.8	16.30
Stock Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	9.7500	9.5746
Warrant Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	0.860	0.851
Est. Term to Business Combination (Yrs)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input | yr	0.35	0.65
Probability of Business Combination
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	85	85
Purchase price of FPA unit
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	10	10

Recurring Fair Value Measurem_6

Recurring Fair Value Measurements - Summary of reconciliation of changes in fair value of derivative warrant liabilities (Detail) - Fair Value, Inputs, Level 3 [Member]	9 Months Ended
	Sep. 30, 2021USD ($)
Derivative Warrant Liabilities [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance	$ 0
Initial value at IPO date	13,712,964
Change in fair value	88,010
Transfer of Public warrants from level 3 to level 1	(8,601,000)
Ending balance	5,199,974
FPA Liability [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance	0
Initial value at IPO date	2,322,741
Change in fair value	484,280
Ending balance	$ 2,807,021

Recurring Fair Value Measurem_7

Recurring Fair Value Measurements - Additional information (Detail)	Sep. 30, 2021USD ($)
Warrant liability	$ 13,800,974
FPA liability
Warrant liability	$ 2,807,021

Commitments & Contingencies - A

Commitments & Contingencies - Additional Information (Detail) - USD ($)	Jun. 11, 2021	Apr. 30, 2021	Dec. 31, 2020	Sep. 30, 2021
Loss Contingencies [Line Items]
Overallotment option vesting period				45 days
Underwriting discount				(2.00%)
Deferred underwriting fee percent on gross proceeds of the IPO				3.50%
Class of warrant or right, exercise price of warrants or rights		$ 10		$ 11.50
Sponsor
Loss Contingencies [Line Items]
Proceeds from issuance of common stock				$ 25,000
Sponsor | Founder Shares [Member]
Loss Contingencies [Line Items]
Stock issued during period, shares, issued for services		25,000
IPO
Loss Contingencies [Line Items]
Cash underwriting discount of the IPO paid to underwriters				$ 4,000,000
Common Class A | Anchor investors
Loss Contingencies [Line Items]
Stock issued during period, shares, issued for services		3,000,000
Common Class A | Sponsor
Loss Contingencies [Line Items]
Proceeds from issuance of common stock		$ 30,000,000
Common stock shares issued with effect of conversion		3,000,000
Common Class A | IPO
Loss Contingencies [Line Items]
Stock shares issued during the period shares	20,000,000
Common Class B | Anchor investors
Loss Contingencies [Line Items]
Stock issued during period, shares, issued for services		375,000
Proceeds from issuance of common stock		$ 0
Common Class B | Anchor investors | Founder Shares [Member]
Loss Contingencies [Line Items]
Stock issued during period, shares, issued for services		375,000
Proceeds from issuance of common stock		$ 0
Common Class B | Sponsor
Loss Contingencies [Line Items]
Stock issued during period, shares, issued for services		750,000	5,750,000
Redeemable Warrants | Anchor investors
Loss Contingencies [Line Items]
Stock issued during period, shares, issued for services		750,000
Maximum | Common Class A | Over-Allotment Option
Loss Contingencies [Line Items]
Stock shares issued during the period shares				3,000,000
Maximum | Private Placement Warrants
Loss Contingencies [Line Items]
Minimum lock in period required for warrant exercise from the date of business combination				30 days

Warrant Liability - Additional

Warrant Liability - Additional Information (Detail) - $ / shares	9 Months Ended
	Sep. 30, 2021	Apr. 30, 2021
Disclosure of Warrant Liability [Line Items]
Class of warrant or right, outstanding	16,000,000
Class of warrant or right, exercise price of warrants or rights	$ 11.50	$ 10
Class of warrant or right, threshold period for exercise from date of closing public offering	12 months
Class of warrant or right redemption threshold consecutive trading days	30 days
Common Class A | Share Price Equal or Exceeds Eighteen Rupees Per Dollar
Disclosure of Warrant Liability [Line Items]
Class of warrant or right, exercise price adjustment percentage higher of market value	180.00%
Common Class A | Share Price Equal or Less Nine Point Two Rupees Per Dollar
Disclosure of Warrant Liability [Line Items]
Share redemption trigger price	$ 9.20
Minimum percentage gross proceeds required from issuance of equity	60.00%
Class of warrant or right, exercise price adjustment percentage higher of market value	115.00%
Public Warrants
Disclosure of Warrant Liability [Line Items]
Class of warrant or right, outstanding	10,000,000
Public Warrants | Share Price Equal or Exceeds Eighteen Rupees Per Dollar
Disclosure of Warrant Liability [Line Items]
Class of warrants redemption price per unit	$ 0.01
Number of days of notice to be given for redemption of warrants	30 days
Number of consecutive trading days for determining share price	20 days
Number of trading days for determining the share price	30 days
Public Warrants | Share Price Equal or Exceeds Ten Rupees Per Dollar
Disclosure of Warrant Liability [Line Items]
Class of warrants redemption price per unit	$ 0.10
Number of days of notice to be given for redemption of warrants	30 days
Number of consecutive trading days for determining share price	20 days
Number of trading days for determining the share price	30 days
Public Warrants | Share Price Equal or Less Nine Point Two Rupees Per Dollar
Disclosure of Warrant Liability [Line Items]
Number of consecutive trading days for determining share price	20 days
Public Warrants | Common Class A | Share Price Equal or Exceeds Eighteen Rupees Per Dollar
Disclosure of Warrant Liability [Line Items]
Share price	$ 18
Public Warrants | Common Class A | Share Price Equal or Exceeds Ten Rupees Per Dollar
Disclosure of Warrant Liability [Line Items]
Share price	$ 10
Private Placement Warrants
Disclosure of Warrant Liability [Line Items]
Class of warrant or right, outstanding	6,000,000

Shareholders' (Deficit) Equity

Shareholders' (Deficit) Equity - Additional Information (Detail) - $ / shares	Jul. 23, 2021	Sep. 30, 2021	Sep. 30, 2021	Jun. 30, 2021	Jun. 11, 2021	Apr. 30, 2021	Dec. 31, 2020
Stock Holders Equity Note [Line Items]
Preferred stock shares authorized		5,000,000	5,000,000				5,000,000
Preferred stock par or stated value per share		$ 0.0001	$ 0.0001				$ 0.0001
Preferred stock shares issued		0	0				0
Preferred stock shares outstanding		0	0				0
Temporary equity, shares outstanding				20,000,000	20,000,000
Sponsor
Stock Holders Equity Note [Line Items]
Preferred stock shares authorized		5,000,000	5,000,000
Preferred stock par or stated value per share		$ 0.0001	$ 0.0001
Preferred stock shares issued		0	0				0
Preferred stock shares outstanding		0	0				0
Number of shares forfeited during the period	750,000
IPO | Sponsor
Stock Holders Equity Note [Line Items]
Percentage of number of shares of common stock outstanding			20.00%
Common Class A
Stock Holders Equity Note [Line Items]
Common stock shares authorized		500,000,000	500,000,000				500,000,000
Common stock par or stated value per share		$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001		$ 0.0001
Common stock shares issued							0
Common stock shares outstanding							0
Temporary equity, shares outstanding		20,000,000	20,000,000				0
Temporary Equity, Shares Issued		20,000,000	20,000,000
Common Class A | Sponsor
Stock Holders Equity Note [Line Items]
Common stock shares authorized		500,000,000	500,000,000
Common stock par or stated value per share		$ 0.0001	$ 0.0001
Common Class B
Stock Holders Equity Note [Line Items]
Common stock shares authorized		50,000,000	50,000,000				50,000,000
Common stock par or stated value per share		$ 0.0001	$ 0.0001				$ 0.0001
Common stock shares issued		5,750,000	5,750,000				6,500,000
Common stock shares outstanding		5,750,000	5,750,000				6,500,000
Number of shares forfeited during the period		750,000
Common Class B | Sponsor
Stock Holders Equity Note [Line Items]
Common stock shares authorized		50,000,000	50,000,000
Common stock par or stated value per share		$ 0.0001	$ 0.0001
Common stock shares issued		6,500,000	6,500,000				6,500,000
Common stock shares outstanding		5,750,000	5,750,000			6,500,000	6,500,000
Common stock shares issued subject to forfeiture		750,000	750,000
Common Class A and Class B | Sponsor
Stock Holders Equity Note [Line Items]
Common stock, Conversion basis			one-to-one